Cardiology
Conference Coverage
For BP screening, shorter rest time yields similar results
The recommended 5-minute rest period before obtaining a clinic blood pressure measurement can be shortened without sacrificing accuracy, a new...
Conference Coverage
Liberalized European sports cardiology guidelines break new ground
The guidelines lift barriers to competitive sports participation by many with cardiovascular diseases.
Conference Coverage
Novel calculator predicts cancer risk in patients with CVD
Individual lifetime total cancer risk ranges from 1% to 52%.
Latest News
The earlier the better for colchicine post-MI: COLCOT
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
From the Journals
MIS-C cardiac evaluation requires more than EF
Conference Coverage
Final EVAPORATE results for Vascepa raise eyebrows
The 18-month data showed high-dose icosapent ethyl significantly cut plaque progression but did little to ease old concerns and raised only new...
Conference Coverage
Early evolocumab quickly lowers LDL cholesterol after primary PCI
Administration of evolocumab after PCI significantly improved LDL cholesterol levels within 4 weeks.
Conference Coverage
LoDoCo2: Added steam for colchicine as secondary prevention
The benefits emerged early and continued to accrue through the trial, with no suggestion of attenuation during up to 5 years of treatment.
From the Journals
Statins linked to reduced mortality in COVID-19
A pooled analysis of available data suggest moderate- to high-intensity statin therapy may be beneficial in patients with COVID-19, researchers...
Conference Coverage
REALITY trial supports restrictive transfusion in anemic MI
Restrictive transfusion proves more effective and less costly than liberal transfusion.
Conference Coverage
First randomized trial reassures on ACEIs, ARBs in COVID-19
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.